To further verify the underlying machinery involved in the CSC-targeted effect of TDB on human lung cancer cells, Akt, an upstream regulatory molecule, was subjected to knockdown in lung cancer H460 cells using specific siRNA. The gene discussed is AKT1; the disease is lung cancer.